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Abstract
Congenital anomalies of the kidney and urinary tract (CAKUT) account for 40–50% of chronic 
kidney disease that manifests in the first two decades of life. Thus far, 31 monogenic causes of 
isolated CAKUT have been described, explaining ~12% of cases. To identify additional CAKUT-
causing genes, we performed whole exome sequencing followed by a genetic burden analysis in 
26 genetically unsolved families with CAKUT. We identified two heterozygous mutations in 
SRGAP1 in 2 unrelated families. SRGAP1 is a small GTPase activating protein in the SLIT2-
ROBO2 signaling pathway, which is essential for development of the metanephric kidney. We 
then examined the pathway-derived candidate gene SLIT2 for mutations in cohort of 749 
individuals with CAKUT and we identified 3 unrelated individuals with heterozygous mutations. 
The clinical phenotypes of individuals with mutations in SLIT2 or SRGAP1 were cystic dysplastic 
kidneys, unilateral renal agenesis, and duplicated collecting system. We show that SRGAP1 is 
expressed in early mouse nephrogenic mesenchyme and that it is coexpressed with ROBO2 in 
SIX2-positive nephron progenitor cells of the cap mesenchyme in developing rat kidney. We 
demonstrate that the newly identified mutations in SRGAP1 lead to an augmented inhibition of 
RAC1 in cultured human embryonic kidney cells and that the SLIT2 mutations compromise the 
ability of the SLIT2 ligand to inhibit cell migration. Thus, we report on two novel candidate genes 
for causing monogenic isolated CAKUT in humans.
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INTRODUCTION
Congenital anomalies of the kidney and urinary tract (CAKUT) account for 40–50% of 
chronic kidney disease that manifests in the first two decades of life (Brakeman 2008; Smith 
et al. 2007). The wide range of structural malformations (e.g. unilateral renal agenesis, 
multicystic dysplastic kidneys, duplex collecting system, vesicoureteral reflux) results from 
developmental defects of the kidneys and/or the urinary tract (Ichikawa et al. 2002; Vivante 
et al. 2014). More than 31 different monogenic causes of isolated CAKUT in humans have 
been described, which account for ~12% of cases (Hwang et al. 2014; Vivante et al. 2014). 
The pathogenetic basis of CAKUT lies in the disturbance of nephrogenesis due to mutations 
in genes that play important roles during kidney development. The underlying molecular 
control of normal nephrogenesis is governed by a large number of genes and signaling 
pathways that orchestrate these complex events. Perturbation in any of these steps can cause 
CAKUT, as supported by mouse models and human disease (Rasouly and Lu 2013; Vivante 
et al. 2014). The metanephric kidney is formed via reciprocal interaction between the 
ureteric bud (UB) and the metanephric mesenchyme (MM), starting at 4 weeks of gestation 
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in humans or on embryonic day 12 in mice. UB outgrowth is considered the initiating event, 
which critically depends on tightly regulated GDNF-RET signaling at the interface of the 
UB and the MM (Costantini and Shakya 2006; Durbec et al. 1996; Jeanpierre et al. 2011; 
Pepicelli et al. 1997; Sanchez et al. 1996; Tang et al. 1998; Vega et al. 1996). Slit2 and 
Robo2 are expressed as ligand and transmembrane receptor in the UB and the MM 
respectively. SLIT2-ROBO2 signaling has been shown to play a role in limiting GDNF-RET 
signaling to the site of the ureteric budding (Grieshammer et al. 2004; Piper et al. 2000). The 
importance of SLIT2-ROBO2 signaling in metanephric kidney development is underlined 
by knockout mouse models for Slit2 and Robo2, as well as heterozygous ROBO2 mutations 
in humans with CAKUT (Grieshammer et al. 2004; Hwang et al. 2014; Lu et al. 2007).
In humans, most CAKUT-causing genes reported to date exhibit an autosomal dominant 
mode of inheritance with variable expressivity and incomplete penetrance (Gbadegesin et al. 
2013; Hwang et al. 2014; McPherson et al. 1987; Sanna-Cherchi et al. 2013). Nevertheless, 
mutations in seven recessive CAKUT-causing genes have recently been discovered 
(Humbert et al. 2014; Kohl et al. 2014; Saisawat et al. 2014).
To identify additional single-gene causes of CAKUT, we conducted whole exome 
sequencing (WES) followed by a burden analysis of novel heterozygous likely pathogenic 
variants in 26 unrelated individuals with CAKUT including their parents. Under the 
assumption that autosomal dominant disease causing genes harbor very few or no 
pathogenic variants in any healthy control cohort due to purifying natural selection, we 
hypothesized that likely pathogenic variants in the same gene in two or more unrelated 
families with CAKUT, with absence of likely pathogenic variants in the same gene from 
control cohorts (positive genetic burden), may indicate causality. Therefore, we compared 
the numbers of likely pathogenic variants per gene in our CAKUT cohort to the numbers of 
different but also likely pathogenic variants in 2,000 Swedish control exomes. Importantly, 
since all considered variants were novel and, hence, absent from the control cohort, we 
merely compared the numbers of different, but equally pathogenic variants as previously 
described by Boyden and colleagues (Boyden et al. 2012).
We identified 29 genes as significantly enriched with potentially pathogenic variants in our 
group of 26 unsolved CAKUT families. Amongst them, SRGAP1 was mutated in two 
families with CAKUT and the only gene functioning in a signaling pathway that previously 
has been implicated in the pathogenesis of CAKUT.
SRGAP1 is a small GTPase activating protein downstream of the extracellular ligand SLIT2 
and the transmembrane receptor ROBO2 that was shown to limit the active state of the 
second messenger RAC1, which is important for cell migration (Li et al. 2006; Wong et al. 
2001; Yamazaki et al. 2013). We and others recently reported on families with heterozygous 
mutations in ROBO2 as a rare monogenic cause of CAKUT (Bertoli-Avella et al. 2008; 
Dobson et al. 2013; Hwang et al. 2014; Jeanpierre et al. 2011; Lu et al. 2007). To obtain 
further evidence for heterozygous mutations in SLIT2-ROBO2 pathway genes on genetic 
ground, we performed high-throughput exon sequencing in SRGAP1 and SLIT2 in a cohort 
of 749 individuals with isolated CAKUT.
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Hence, we chose to focus on investigating a potential causative role of the newly identified 
variants in SRGAP1 and to identify additional mutations in the ligand SLIT2 in other 
families with CAKUT.
Here we describe and functionally characterize two novel heterozygous variants in SRGAP1 
and three novel heterozygous variants in SLIT2. We demonstrate that Srgap1 is expressed in 
early mouse nephrogenic mesenchyme and that SRGAP1 and ROBO2 colocalize to the cap 
mesenchyme in developing rat kidney. Our functional studies further show that the newly 
identified SRGAP1 mutations cause augmented inhibition of RAC1, whereas the newly 
identified SLIT2 mutations diminish its inhibitory effect on neuronal cell migration. We thus 
present further evidence that heterozygous mutations in SLIT2, ROBO2, and SRGAP1 confer 
risk for developing CAKUT.
MATERIALS AND METHODS
Human subjects
Following informed consent, we obtained clinical data, blood samples, and pedigrees from 
individuals with CAKUT. The study was approved by the institutional review board (IRB) 
of the University of Michigan Medical School, Boston Children’s Hospital, and local IRBs 
according to the Declaration of Helsinki. Patients were included in the study if a diagnosis 
compatible with CAKUT was established by a pediatric nephrologist or (pediatric) urologist. 
The study comprised 749 individuals from 650 different families with CAKUT from 25 
different pediatric nephrology units worldwide. Heterozygous exonic mutations in the 
following 23 genes that are known to cause isolated CAKUT in humans were excluded prior 
to this study: BMP4, BMP7, CDC5L, CHD1L, EYA1, GATA3, HNF1B, PAX2, RET, 
ROBO2, SALL1, SIX1, SIX2, SIX5, SOX17, UMOD, UPK3A, FRAS1, FREM2, FREM1, 
GRIP1, ITGA8, and GREM1. HNF1B–deletions were excluded by quantitative PCR in 
individuals with the CAKUT phenotype of renal hypodysplasia.
Whole exome sequencing
For a group of 26 CAKUT families, which remained genetically unsolved in two previous 
targeted sequencing studies, whole exome sequencing (WES) and a variant burden analysis 
was performed as described previously (Boyden et al. 2012; Hwang et al. 2014; Kohl et al. 
2014). Variants with minor allele frequencies <1% in the Yale (1,972 European subjects), 
NHLBI GO Exome Sequencing Project (4,300 European and 2,202 African American 
subjects; last accessed November, 2012), dbSNP (version 135) or 1,000 Genomes (1,094 
subjects of various ethnicities; May, 2011 data release) databases were selected and 
annotated for impact on the encoded protein and for conservation of the reference base and 
amino acid among orthologs across phylogeny.
For a variant burden analysis likely pathogenic variants detected in the present CAKUT 
cohort were compared to different, but also likely pathogenic variants of 2,000 Swedish 
control exomes as previously described (Boyden et al. 2012). A Fisher exact test was used to 
determine significant enrichment of potentially pathogenic variants (p<1.0E-5) in certain 
genes in the CAKUT cohort. Variants were considered “potentially pathogenic” if they were 
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either missense variants affecting amino acid residues evolutionary conserved in vertebrates, 
splice-site or nonsense variants and absent from large variant databases (EVS, 1000 
Genomes, Yale in-house variant database).
Candidate gene mutation analysis
All coding exons of SRGAP1 and SLIT2 were sequenced by microfluidic PCR (Fluidigm®) 
and next-generation sequencing (MiSeq®, Illumina) as described previously by our group 
(Halbritter et al. 2012; Halbritter et al. 2013). Exon-flanking oligonucleotide sequences for 
all coding exons of SRGAP1 and SLIT2 are available from the authors. Detected variants 
were filtered against public variant databases (1,000 Genomes and NHLBI GO Exome 
Sequencing Project) and only novel variants were considered. Following evolutionary 
conservation analysis, identified mutations were confirmed by Sanger sequencing of 
genomic DNA.
Immunofluorescence
Immunofluorescence imaging (IF) was performed on rat kidney sections using a Leica SP5X 
system with an upright DM6000 compound microscope as previously described by the 
authors (Chaki et al. 2012). Images were processed with the Leica AF software suite. The 
following primary antibodies were used: SRGAP1 (Santa Cruz Biotechnology, Cat# 
sc-81939), ROBO2 (Santa Cruz Biotechnology, Cat# sc-31607), SIX2 (abcam, Cat# 
ab68908), WT1 (Santa Cruz Biotechnology, Cat# sc-192).
RAC1 and CDC42 activity assay
RAC1/CDC42 activity assays were performed according to Pellegrin et al. (Pellegrin and 
Mellor 2008). Briefly, the GST-PAK1 CRIB domain was purified from the BL21 (DE3) E. 
coli. HEK293T cells were transfected with wild-type or mutant SRGAP1 using FuGene HD 
transfection reagent (Promega). Cells were collected 48 hours post-transfection, rinsed with 
PBS, lysed, and subjected to GST pull-down for 2 hours at 4°C. GST beads were washed 5 
times followed by elution with sample buffer. GTP-bound CDC42 and RAC1 were analyzed 
by Western blotting using anti-CDC42 and anti-RAC1 antibodies (#610929 and #610651, 
BD Transduction Laboratories). Input controls were analyzed using anti-SRGAP1 
(#H00057522-M07, Abnova) and anti-β-actin antibody (ab20272, Santa Cruz 
Biotechnology).
Anterior subventricular zone neuron migration assay
To make conditioned media of human SLIT2 and its mutants, 80% confluent HEK293T 
cells were transiently transfected to express SLIT2 using calcium phosphate. 24 hours after 
transfection, the cell media were replaced with fresh 10% FCS DMEM and incubated in 5% 
CO2 incubator at 37°C for three days. SLIT2 conditioned medium was then collected from 
SLIT2 overexpressing HEK293T cells for functional anterior subventricular zone (SVZa) 
neuron migration assay. Migrating SVZa cells were dissected from the rostral migratory 
stream of postnatal rat brains at days 1–5 as described previously.(Ward and Rao 2005) The 
SVZa cell explants were cultured in a 3:2:1 collagen:matrigel:DMEM mixed gel in the 
presence of wild-type human SLIT2 or mutant SLIT2 conditioned media for 24 hours. SVZa 
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cells were fixed in 4% PFA and images were taken under a 10x DIC microscope. DIC 
images were converted in 8-bit grey-scale images and contrast was increased by 1% (ImageJ 
software; http://imagej.nih.gov/ij). To identify and count migrated cells, matrigel shadows 
were electronically enlarged by 250% leaving only migrated cells in the periphery visible 
(Supplementary Figure 6 online). In detail, matrigel shadows were selected using the “Fuzzy 
select” tool in GIMP2.8 image software (www.gimp.org) with a threshold of 15. The content 
of the selected area was deleted and filled with black using the “Bucket fill” tool. 
Subsequently, the black area was enlarged proportionally by increasing length and width by 
250% while keeping the center fixed. Following this masking procedure, remaining visible 
cells were counted using the “cell counter” plugin of ImageJ. Additionally, cell migration 
distances out of SVZa explants were measured in ImageJ. The length of two migration 
distances was measured per quadrant. Hence, 24 migration distances were obtained per 
triplicate. P-values were calculated using the one-tailed Student’s t-test.
RESULTS
Exome sequencing and burden analysis in patients with CAKUT reveals likely pathogenic 
variants in SRGAP1
Since CAKUT are most frequently inherited in an autosomal dominant mode with 
incomplete penetrance, we hypothesized that different novel heterozygous mutations in the 
same gene in two or more unrelated individuals with CAKUT could represent monogenic 
causes for CAKUT. Hence, we performed whole exome sequencing (WES) in 98 
individuals from 26 unrelated families with isolated CAKUT. The 26 families included in 
the present WES study all had an affected child with a diagnosis of the CAKUT spectrum 
and they all remained genetically unsolved after 2 previous targeted sequencing studies 
comprising 23 known CAKUT genes (Hwang et al. 2014; Kohl et al. 2014). A burden 
analysis of novel potentially pathogenic variants in all 26 affected families revealed 29 
genes as significantly enriched with novel potentially pathogenic variants as compared to 
2,000 Swedish control exomes. Since we only considered novel variants we used a large 
control cohort regardless of their ethnical background as previously described by one of the 
co-authors (Boyden et al. 2012). We identified two affected individuals and one affected 
mother from two unrelated families harboring different heterozygous mutations in SRGAP1 
(Table 1 and Figure 1). In family A4732 of European origin, the index patient A4732-21 and 
his mother were affected. A4732-21 was diagnosed prenatally with a right multicystic 
dysplastic kidney (MCDK). At 2.5 years of age there was no renal tissue detectable on renal 
ultrasound, indicating that the dysplastic kidney remnant had undergone complete involution 
(Figure 1A). Ultrasound examination of the patient’s asymptomatic mother, A4732-12, 
demonstrated right non-obstructive duplex kidney (Figure 1B). Both, the index patient and 
his mother were heterozygous for the SRGAP1 mutation c.806G>A, leading to the amino 
acid substitution p.C269Y (Table 1 and Figure 1E–G). The missense mutation p.C269Y 
affects an amino acid residue conserved in vertebrates and is absent from public variant 
databases (>17,000 control chromosomes of the NHLBI Exome Sequencing Project and the 
1000 Genomes Project) and from 1,972 European subjects in the in-house Yale variant 
database. In the individual A1041-21 of Arabic/European descent with caudally fused 
kidneys (horseshoe kidney) including a multicystic dysplastic right upper pole, a 
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hypodysplastic left upper pole and extra-renal features, we detected the heterozygous 
SRGAP1 mutation c.1993C>A, causing an amino acid exchange in a conserved residue, 
p.P665T (Table 1 and Figure 1). The mutation was inherited from the father, who was 
clinically not affected. The father was not available for renal ultrasound examination. In 
order to identify additional families with SRGAP1 mutations, we screened for mutations in 
SRGAP1 in our previously described cohort of 845 affected individuals with CAKUT, which 
did not reveal additional affected families (Hwang et al. 2014; Sanchez et al. 1996). 
However, since potentially pathogenic variants in SRGAP1 were significantly enriched in 
our CAKUT cohort and since SRGAP1 is a molecular interactor of the ROBO2 receptor, a 
known CAKUT-causing gene, we chose to conduct further functional studies to investigate 
causality of the newly identified SRGAP1 mutations (Wong et al. 2001).
SRGAP1 is expressed in early mouse nephrogenic mesenchyme and colocalizes with 
ROBO2 to the cap mesenchyme of developing rat kidneys
To examine the role of SRGAP1 during normal kidney development, we analyzed a Srgap1-
lacZ reporter mouse line (Supplementary Figure 1 online). β-galactosidase staining for cells 
from Srgap1 promoter-driven lacZ reporter expression at E11.5 detected Srgap1 in the 
developing nephrogenic mesenchyme, including the mesonephros and metanephros 
(Supplementary Figure 1 online). We confirmed expression of Srgap1 in metanephric 
mesenchyme at E13.5 and E14.5 by in situ hybridization (Supplementary Figure 2 online). 
Srgap1-expressing cells were absent from the E11.5 mouse nephric duct and the ureteric 
bud, which is consistent with what is described for Robo2 during early mouse kidney 
development.14 This also is in line with microarray gene expression data in the Gudmap 
expression database (www.gudmap.org) (Supplementary Figure 3 online). To further relate 
SRGAP1 expression pattern to renal developmental phenotypes, we performed 
immunofluorescence staining of SRGAP1 in kidneys of embryonic and newborn rats (E16.5 
and P0, respectively). We found Srgap1 to be expressed in rat kidney at E16.5 (Figure 2A
+B) and P0 (Figure 2C+D), whereas we did not detect SRGAP1 in adult rat kidney (data not 
shown). During rat kidney development, we found SRGAP1 to be expressed in renal 
mesenchyme where it colocalizes with ROBO2 in SIX2-positive cap mesenchyme (Figure 
2A–D). We detected the strongest overlap of the SRGAP1 and ROBO2 signals at the 
ureteric bud-facing pole of the cap mesenchyme, strongly suggesting active SLIT2-ROBO2-
SRGAP1 signaling at this site (Figure 2B). These data are highly consistent with the 
CAKUT phenotype observed in individuals with heterozygous SRGAP1 mutations. 
Additionally, Srgap1 is expressed in developing podocytes, suggesting an additional 
function here, which is in line with previous work describing podocytes as Robo2-
expressing cells (Figure 2 A, C, D, and Supplementary Figure 4 online) (Fan et al. 2012; 
Lindenmeyer et al. 2010).
SRGAP1 mutations cause augmented inhibition of RAC1
SRGAP1 has been shown to act down-stream of SLIT2-ROBO2 and to reduce the GTP-
bound (active) state of RAC1, which is important for lamellipodial extension and retraction 
cycles in cell migration (Wong et al. 2001; Yamazaki et al. 2013). We hypothesized that the 
newly identified mutations in SRGAP1 in families with CAKUT may have an effect on 
RAC1 and CDC42 activity, which could alter cell migration of the cap mesenchyme during 
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kidney development. Hence, we studied RAC1 and CDC42 activity using a PAK1-assay in 
human embryonic kidney cells (HEK293T) transiently overexpressing wild-type SRGAP1 
versus mutant SRGAP1 proteins (Figure 3). Interestingly, we found that the mutant 
SRGAP1 proteins p.C269Y and p.P665T shared an increased inhibition on RAC1 activity as 
compared to wild-type SRGAP1 indicating a gain-of-function effect of the mutations 
(Figure 3). CDC42 activity was unchanged (Supplementary Figure 5 online).
Novel pathogenic variants in SLIT2 cause CAKUT in humans
Next, we aimed to identify additional CAKUT-causing genes that are a component in the 
SLIT2-ROBO2-SRGAP1 signaling pathway. We and others have recently published that 
heterozygous ROBO2 mutations cause CAKUT in humans and mice (Hwang et al. 2014; Lu 
et al. 2007). Intriguingly, mutated SLIT2 has been reported to cause a CAKUT phenotype in 
a knockout mouse model making it a promising candidate gene for human CAKUT 
(Grieshammer et al. 2004). In order to identify SLIT2 mutations in patients with CAKUT we 
utilized high-throughput exon sequencing to screen for mutations in SLIT2 in 749 affected 
individuals with CAKUT (Hwang et al. 2014; Sanchez et al. 1996). We identified three 
unrelated individuals with three different heterozygous SLIT2 missense mutations affecting 
conserved amino acid residues which were absent from public variant databases (Table 1, 
Figure 1H–J). Individual A3748-21 with multiple subcortical cysts in both kidneys had the 
mutation SLIT2 c.292G>A, p.A98T (Table 1 and Figure 1H–J). Individual A4736-21 with 
right MCDK was found to have SLIT2 c.1697G>A, p.S566N (Table 1 and Figure 1H–J). 
Interestingly, as described in individual A4732-21 with an SRGAP1 mutation, this individual 
also showed MCDK and complete involution (Figure 1C–D). The third individual, 
A3468-21, who was diagnosed with right renal agenesis at 14 years of age, had the mutation 
SLIT2 c.2712A>T, p.K904N (Table 1 and Figure 1H–J).
SLIT2 mutations cause reduced inhibition of cell migration
Knockout mice lacking Slit2 develop supernumerary ureteric buds that remain 
inappropriately connected to the nephric duct, resulting in CAKUT in the form of multiple 
ureters and fused dysplastic kidneys (Grieshammer et al. 2004). The SLIT2 protein has a 
well-studied function as a chemorepellent in neuronal cell migration (Brose et al. 1999; 
Nguyen Ba-Charvet et al. 1999). Given the CAKUT phenotype of the Slit2 knockout mouse 
model, we hypothesized that the newly identified mutations in SLIT2 would alter its 
chemorepulsive activity. To test this hypothesis, we studied the function of SLIT2 mutants 
on anterior subventricular zone (SVZa) cell migration (Ward and Rao 2005). Neuron 
precursor cells from the rat olfactory bulb express ROBO2 receptors and are repelled by 
wild-type SLIT2 (Nguyen-Ba-Charvet et al. 2004). In this model, we overexpressed wild-
type SLIT2 and mutants in HEK293T cells and harvested SLIT2-conditioned media 72 
hours after transfection. SVZa cell migration in the presence of wild-type SLIT2 or mutant-
conditioned media was analyzed after 24 hours by counting migrated cells (Figure 4 and 
Supplementary Figure 6 and Supplementary Figure 7 online). We observed the expected 
radial migration of cells in the conditioned media from mock-transfected HEK293T cells. 
SLIT2 wild-type conditioned media strongly inhibited cell migration (Figure 4 and 
Supplementary Figure 6 and Supplementary Figure 7 online). However, the SLIT2 mutations 
p.A98T, p.S566N, and p.K904N compromised the inhibition of SVZa cell migration, 
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suggesting a loss-of-function effect (Figure 4 and Supplementary Figure 6 and 
Supplementary Figure 7 online).
DISCUSSION
In the present study we identified two different heterozygous mutations in SRGAP1 and 
three different heterozygous mutations in SLIT2 in families with isolated CAKUT. We 
showed that Srgap1 is specifically expressed in the early nephrogenic mesenchyme in mice 
and the metanephric mesenchyme in rats where it colocalizes with the transmembrane 
receptor ROBO2 during metanephric kidney development. We demonstrated that the newly 
discovered SRGAP1 mutations have a gain-of-function effect in a RAC1 activity assay and 
that the mutated SLIT2 proteins exhibit a loss-of-function effect in repelling migrating 
SLIT2-sensitive cells in a SVZa assay. Although we have not studied the effect of the newly 
identified mutations in Knock-in murine transgenic models to generate direct evidence for a 
causative role of the newly described mutations, causality is strongly supported by the 
aforementioned assays and by genetic evidence on a gene and variant level according to 
recent guidelines (MacArthur et al. 2014). Hence, we presented evidence that heterozygous 
mutations in the SLIT2-ROBO2-SRGAP1 signaling pathway may confer risk for developing 
CAKUT in humans.
Our current model of pathogenesis in humans with CAKUT and SLIT2-ROBO2-SRGAP1 
mutations is based on accumulating evidence that imbalances of a tightly balanced small 
GTPase network interferes with migrating cells of the ureteric bud and the metanephric 
mesenchyme during kidney development. The ligand SLIT2 is expressed in the nephric 
duct, ureteric bud, and ureteric tips (Supplementary Figure 3 online), whereas its receptor 
ROBO2 is expressed in the adjacent metanephric mesenchyme. The present work adds 
SRGAP1 as a downstream effector to the established SLIT2-ROBO2 signaling pathway 
during kidney development. The newly identified deactivating SLIT2 mutations and 
activating SRGAP1 mutations do not allow a harmonic conclusion that either up- or down-
regulation of SLIT2/ROBO2/SRGAP1 signaling causes CAKUT, because our study showed 
that gain-of-function mutations in SRGAP1, as well as loss-of-function mutations in SLIT2 
may be pathogenic. Instead, we conclude that both up- or down-regulation of a tightly 
balanced small GTPase network can lead to disease. Following our in-vitro functional 
studies it will be necessary to directly observe the behavior of the mutated proteins during 
metanephric kidney development, preferably in transgenic knock-in animal models.
The predominant phenotypes in individuals with heterozygous mutations in either SLIT2 or 
SRGAP1 were multicystic dysplastic kidneys that undergo complete involution during 
childhood. This fact is suggestive for a pathway-phenotype correlation, although more cases 
SUPPLEMENTAL DATA
Supplementary Figure 1. Srgap1 is expressed in early mouse developing kidney.
Supplementary Figure 2. Srgap1 is expressed in mouse metanephric mesenchyme and developing glomeruli at E13.5 and E14.5.
Supplementary Figure 3. Srgap1 and Robo2 are coexpressed in metanephric mesenchyme, cap mesenchyme, and renal corpuscles in 
mice at E.11.5 and E15.5 Slit2 is expressed in ureteric bud and ureteric tip at E11.5 and E15.5.
Supplementary Figure 4. SRGAP1 partially colocalizes with ROBO2 in developing podocytes.
Supplementary Figure 5. Overexpression of mutant SRGAP1 does not alter CDC42 activity in cultured HEK293T cells.
Supplementary Figure 6. Mutations in SLIT2 detected in individuals with CAKUT reduce the chemorepulsive effect of SLIT2.
Supplementary Figure 7. Similar amounts of SLIT2 proteins present in the conditioned media used for the SVZa assay (Figure 4).
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and larger pedigrees are needed before we can draw this conclusion and attribute monogenic 
causality. The presence of unilateral MCDK as a genetic disease seems counterintuitive. 
However, this is a very common presentation of monogenic CAKUT cases and does not 
argue against a genetic etiology (Hwang et al. 2014). In family A1041 the affected child 
inherited the SRGAP1 mutation from a healthy father with a normal renal ultrasound. This 
family may represent a case of incomplete penetrance, which is a common finding in 
CAKUT, and thus does not exclude causality. In this case the treating physician had lost 
contact with the family and we were not able to obtain renal ultrasounds in other family 
members.
In summary, by discovery of mutations in SLIT2 and SRGAP1 we implicated multiple 
components of a coherent signaling pathway in the pathogenesis of human CAKUT.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Ultrasonographic findings in two families with CAKUT and localization of newly 
identified mutations in SRGAP1 and SLIT2 cDNAs and proteins
(A) Renal ultrasonography of individual A4732-21 at age 6 months (SRGAP1 mutation) 
showing absence of renal tissue on the right side (black arrow-head) at the expected location 
adjacent to the liver (Li). The left kidney (K) shows compensatory hypertrophy. Prenatally, 
right multicystic dysplastic kidney (MCDK) was diagnosed (not shown).
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(B) Renal ultrasonography of the patient’s mother (SRGAP1 mutation) showing separation 
of the central echogenic complex in the right kidney (white arrow-head) indicating a non-
obstructive duplex kidney. The left kidney is normal.
(C) MCDK on the right side in individual A4736-21 (SLIT2 mutation) at age 3 months 
(white arrow-heads denote two large cysts).
(D) In the same individual, at age 2.5 years, no renal tissue was detectable on ultrasound on 
the right (black arrow-head), indicating complete involution of the MCDK. The left kidney 
(K) shows compensatory hypertrophy.
(E) Exon structure of human SRGAP1 cDNA. The position of the start codon (ATG) and 
stop codon (TGA) are indicated.
(F) Domain structure of the SRGAP1 protein.
(G) Mutations detected in SRGAP1 in two families with CAKUT (family identifiers are 
underlined) are depicted as black arrows indicating their positions in relation to exons and 
protein domains (see also Table 1).
(H) Exon structure of human SLIT2 cDNA.
(I) Domain structure of SLIT2.
(J) Mutations of SLIT2 detected in three unrelated individuals with CAKUT (see also Table 
1).
aa, amino acids; bp, base pairs; CT, C-terminal cysteine knot domain; EGF, epidermal 
growth factor-like domain; FCH, Fes/CIP4 homology domain; IF-BAR, inverse F-BAR 
domain; K, kidney; LamG, laminin G domain; L, left; Li, liver; LRR, leucin-rich repeat 
domain; R, right; RhoGAP, GTPase-activator protein for Rho-like GTPases domain; SH3, 
Src homology 3 domain.
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Figure 2. SRGAP1 is coexpressed with ROBO2 in cap mesenchyme in rat kidney at E16.5 and P0
Immunofluorescence microscopy of sections of rat kidneys at E16.5 (A and B) and at P0 (C 
and D).
(A–B) ROBO2 (green) is expressed in SIX2-positive (blue-green) cap mesenchyme and 
developing glomeruli. SRGAP1 (red) colocalizes with ROBO2 in cap mesenchyme.
(B) Enlargement from (A). Note that the overlap of ROBO2 and SRGAP1 (yellow) in cap 
mesenchyme is most prominent at the ureteric tip-facing pole of the cap mesenchyme 
(arrows) indicating active ROBO2-SRGAP1 signaling at this site.
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(C–D) ROBO2 is expressed in SIX2-positive cap mesenchyme (arrow-heads) and in 
different stages of development of glomerular podocytes (C, comma-shaped body; CL, 
capillary loop stage glomerulus; G, mature-appearing glomerulus).
(C) Overview of renal cortex showing different stages of embryonic nephron development. 
The nephrogenic zone is marked by SIX2-positive cap mesenchyme directly underneath the 
renal capsule (arrow-heads). Different stages of glomerular development on a gradient from 
early (C, CL) to late (G) express ROBO2 and SRGAP1.
(D) SRGAP1 (red) is coexpressed with ROBO2 (green) in cap mesenchyme (arrow-heads) 
and highly expressed in developing podocytes in capillary loop stages glomeruli (arrows).
Scale bar: 50µm.
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Figure 3. RAC1 activity is reduced upon overexpression of SRGAP1 mutants in cultured 
HEK293T cells
(A) Active GTP-bound RAC1 precipitated by GST-PAK1 pulldown (PD) from HEK293T 
cells transfected with wild-type (WT) versus mutant SRGAP1 constructs. Note that 
HEK293T cells transfected with human SRGAP1 mutants C269Y and P665T exhibit an 
enhanced decrease in RAC1 activity compared to wild-type SRGAP1. The efficiency of 
SRGAP1 transfections and 5% input control were confirmed by immunoblotting with anti-
SRGAP1 and anti-actin antibodies, respectively.
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(B) Relative RAC1 activities (PAK1-bound RAC1/total RAC1) based on anti-RAC1 
immunoblot signal intensities in (A). Ratios are normalized to mock transfection. A and B 
represent 5 experiments each.
*, P< 0.05 (Student’s t-test); Error bars indicate one standard deviation (n=3).
Hwang et al. Page 19
Hum Genet. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 4. SLIT2 mutations identified in CAKUT patients compromise its inhibition of SVZa 
neuronal migration
(A) Representative DIC images show SVZa neuronal migration after 24 hours in the 
presence of SLIT2 wild-type (WT) or SLIT2 mutants (A98T, S566N, K904N) conditioned 
media. Media from mock transfected HEK293T cells were used as a negative control. Note 
that wild-type SLIT2 inhibits neuronal migration whereas the SLIT2 mutants show a 
diminished inhibition. Dot circles in processed image column represent the areas where the 
number of migrated cells out of SVZa explants and migration distance were quantified (see 
also Supplementary Figure 6 online).
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(B) Quantification of migrated SVZa cell counts in (A). Note wild-type SLIT2 has less 
migrated cells out of SVZa explants. SLIT2 mutants A98T, S566N, and K904N show a 
diminished inhibitory effect on migrated cell counts.
(C) Quantification of average SVZa cell migration distances in (A). Note wild-type SLIT2 
inhibits migration of SVZa cells. SLIT2 mutants A98T, S566N, and K904N show a reduced 
inhibitory effect on migration indicating partial loss-of-function.
Scale bar: 100µm.
*, P< 0.05 (Student’s t-test); Error bars indicate one standard deviation (n=3).
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